Cytocom CEO launches $115M SPAC

FORT COLLINS — Another special purpose acquisition company is preparing to launch along the northern Front Range with Cytocom Inc. CEO Michael Handley at the helm.

Sparta Healthcare Acquisition Corp. is seeking to raise up to $115 million in a bid to join the Nasdaq Capital Market under the ticker “SPTAU”, according to preliminary S-1 filings with the U.S. Securities and Exchange Commission Wednesday afternoon.

Special purpose acquisition companies, or SPACs, are shells that are listed on public exchanges and later acquire or merge with companies looking to go public outside of the normal procedures of an initial public…